account_id none on file
legal_name bioAffinity Technologies, Inc.
ticker BIAF
cik 1712762
domain bioaffinitytech.com
linkedin_company_url https://www.linkedin.com/company/bioaffinitytechnologies/
entry_point_account_id none on file
name bioAffinity Technologies Inc.
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 0 filings 93 executives 3 family 0
why_nownone on file
callsnone on file
filings
Company has one operating lease for its real estate and office space for the CAP/CLIA laboratory, as well as multiple finance leases
filing / Aug 7, 2026 / receipt
office space. The Company entered into a new operating lease agreement for additional lab space in June 2026. The Company’s operating
filing / Aug 7, 2026 / receipt
Company has one operating lease for its real estate and office space for the CAP/CLIA laboratory, as well as multiple finance leases
filing / May 11, 2026 / receipt
September 1, 2024 for additional office space. The Company’s operating leases consist of office and lab space with remaining
filing / May 11, 2026 / receipt
Entered major VA medical centers with lung nodule programs
ir_statement / Sep 17, 2026 / receipt
Phased market expansion in Northeast and Southern US
ir_statement / Sep 17, 2026 / receipt
Entered major VA medical centers with lung nodule programs
ir_statement / Sep 17, 2026 / receipt
Phased market expansion in Northeast and Southern US
ir_statement / Sep 17, 2026 / receipt
Entered major VA medical centers with lung nodule programs
ir_statement / Sep 17, 2026 / receipt
Phased market expansion in Northeast and Southern US
ir_statement / Sep 17, 2026 / receipt
Entered major VA medical centers with lung nodule programs
ir_statement / Sep 17, 2026 / receipt
Phased market expansion in Northeast and Southern US
ir_statement / Sep 17, 2026 / receipt
executives
| J. Michael Edwards | Interim Chief Financial Officer | - | receipt |
| Michael Edwards | Interim Chief Financial Officer | - | receipt |
| Xavier Reveles | Vice President | - | receipt |
familynone on file
upcoming
| 2026-11-13 | earnings call | scheduled | ir |
changes
| 2024-10-10 | Interim Chief Financial Officer, appointed | sec_8k |
| 2024-08-23 | Interim Chief Financial Officer, appointed | sec_8k |
| 2023-09-20 | Vice President, appointed | sec_8k |
mcp_package_hint
slug bioaffinity-technologies-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$